The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Global

Kips Bay Medical Granted First US Patent and Received Notice of Allowance on a Second US Patent Application

22-Sep-2011 | Source : | Visits : 7860
MINNEAPOLIS - Kips Bay Medical announced in a press release that the United States Patent and Trademark Office (USPTO) has issued to the Company patent number 7,998,188, titled "Compliant Blood Vessel Graft," which includes eleven permitted claims covering the Company's core eSVS(R) MESH technology, and represents the first patent obtained in the United States covering this technology.

The USPTO has also issued a Notice of Allowance approving a second patent application, titled "Compliant Venous Stent," which includes three claims related to the eSVS MESH design.

"This is great news for the Company," stated Manny Villafaña, Chairman and Chief Executive Officer. "We believe that the issuance of this patent and the approval of this patent application provide the foundation for very strong and broad-based protection for our eSVS MESH. These are important milestones in the development and growth of our intellectual property portfolio and securing our leadership position in cardiovascular bypass surgery."

At present, the Company possesses issued patents in Japan and Canada covering the eSVS MESH. In addition, it has received a Notice of Allowance from the European Patent Office and is presently engaged in the grant phase to validate the European patent in eight European Countries. The company is pursuing additional patent applications which are pending in the United States and in strategic countries world-wide.

Kips Bay Medical Inc., founded in 2007 and headquartered in Minneapolis, Minnesota, is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, or eSVS MESH for use in coronary artery bypass grafting surgery.

Related Articles